<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Cell and Developmental Biology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/35D2CF05-BE6B-4818-9EC1-CC28950C98B7"><gtr:id>35D2CF05-BE6B-4818-9EC1-CC28950C98B7</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Nicholas</gtr:otherNames><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G9717869"><gtr:id>70172B02-58D5-4A42-B8A6-04A3AEEFF7E5</gtr:id><gtr:title>Mechanisms of Nociception and Pain</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9717869</gtr:grantReference><gtr:abstractText>Although pain is useful because it protects us from harming ourselves, and may also signal the beginnings of disease, inappropriate chronic pain associated with disease can dramatically diminish quality of life. Millions of people suffer from conditions such as chronic back pain, and pains related to damaged nerves in the skin, caused by conditions ranging from diabetes to AIDS. Pain caused by light touch is a particularly troublesome aspect of some pain syndromes. Surprisingly most drugs that are used to treat pain are quite old, and have undesirable side effects - for example morphine causes addiction and can inhibit breathing, whilst aspirin causes stomach bleeding and is not effective in many long term pain conditions. Thus considerably more than half of chronic pain patients (hundreds of thousands of people in the UK alone) are inadequately treated. One drug that seems to work (in about a third of people) called gabapentin has been proposed to act by blocking the actions of a protein involved with sending electrical messages into the spinal cord.
 In the programme of work described here, we show how we will use mice to identify the molecules involved in detecting painful mechanical stimuli. Once we have established how mechanical forces are sensed at a molecular level, we can design methods to identify chemicals that can block this sensation. Such chemicals can be developed into drugs, hopefully without side effects, that act to block mechanically-induced pain, but not the sensation of touch. We have found a snail toxin that blocks mechanically activated electrical signals in nerve cells. We can tag the toxin to find the proteins that it sticks to, and then find the genes that encode these proteins. Next we make mice where we have deleted the genes that encode the proteins to see if they no longer feel unpleasant mechanical stimuli. We know how to delete genes just in damage-sensing nerves. We are already using this approach to find out how important various proteins involved with electrical signalling are for pain perception. We can also use this technology to find out if Gabapentin, the new chronic pain drug, really does work in the way it is supposed to, and if not how it does work, and how various signalling molecules change pain thresholds by sending messages into the spinal cord. We are very confident our work will lead to useful new pain-killers.</gtr:abstractText><gtr:technicalSummary>We plan to continue our studies on sensory neuron function, focussing particularly on noxious mechanosensation which is a major clinical problem in pain control. We aim to identify molecular components of the mechanosensory apparatus and test their function using genetic approaches. We are also using sensory neuron specific Cre-recombinase mice to delete genes only in sensory neurons. We plan to develop this technology so that we can also delete genes in a temporally controlled manner in adult sensory neurons to avoid problems of developmental compensatory mechanisms. The specific projects that we plan to carry out include;
1) An investigation of the possible role of acid sensing ion channels and their interacting proteins in mechanosensation.
2) Expression cloning of mechanosensory molecules using a specific conotoxin channel blocker. 
3) Generation of a new ligand-activatable nociceptor-specific Nav1.8Cre-ERt mouse to delete genes only in sensory neurons in adult mice.
4) Use of the Nav1.8-Cre mouse to prove whether Gabapentin acts on alpha-2-delta-1 calcium channel subunits to inhibit neuropathic pain
5) Definition of the roles of BDNF in peripheral pain processing 
6) Expansion of the application of DRG-specific gene deletion to other targets as resources allow.</gtr:technicalSummary><gtr:fund><gtr:end>2009-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2513777</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>TV appearance</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0603115E-B491-49F1-9D04-02BD2C52E6D2</gtr:id><gtr:impact>Secret world of pain had an audience of 2.5 - 3 million

many letters from public in pain!</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Conference - Royal Society - Institute of Basic Science Korea</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7479C186-34E3-48EE-AB08-4752081905DF</gtr:id><gtr:impact>Very successful first conference - top be followed up in 2015 in the UK with another meeting

UK Korean Government enhanced research collaboration</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>650000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>London Pain Consortium</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>JLHRBMR</gtr:fundingRef><gtr:id>2FB63885-DF7B-4195-A0E3-5554EB6A2353</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>363000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Horizon 2020</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>European Union</gtr:fundingOrg><gtr:fundingRef>H2020-MSCA-ITN-2014-642720</gtr:fundingRef><gtr:id>0C611A97-8E21-47DF-B788-A6D74C428B2B</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Investigator Award</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>101054/Z/13/Z</gtr:fundingRef><gtr:id>7208012A-D9B3-46E7-954F-C25AAD34BC1B</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Collaborative Award</gtr:description><gtr:end>2021-01-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>200183/Z/15/Z</gtr:fundingRef><gtr:id>AA0E2049-28D6-4372-8BFE-84C952D40CA7</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The present invention relates a pharmaceutical composition comprising (a) an opioid analgesic drug and/or an enkephalinase inhibitor, and (b) a selective Nav1.7 inhibitor.</gtr:description><gtr:id>5872A12A-5996-465B-905A-D81926CC867E</gtr:id><gtr:impact>In progress</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>wo2015036734</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>SYNERGISTIC COMBINATION OF ANALGESIC DRUGS</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We deposited our inducible Cre ERT2 mice at Harwell.</gtr:description><gtr:id>E6A17A45-04AC-4EE4-8CF7-94D2F9B121C0</gtr:id><gtr:impact>This has been a fantastic tool, for target validation. We predicted the importance of Nav1.7 as a drug target, and helped the human geneticists who confirmed this.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>transgenic mouse models of human disease</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Now more than 20 new mouse lines for pain research</gtr:description><gtr:id>3E13B4DE-600B-4A36-AA7D-A80F4D2D07AC</gtr:id><gtr:impact>Many joint publications - this effort in terms of mouse production continues.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>many transgenic mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AE95DE41-8797-41D6-9197-CF7CF969042E"><gtr:id>AE95DE41-8797-41D6-9197-CF7CF969042E</gtr:id><gtr:title>High-threshold mechanosensitive ion channels blocked by a novel conopeptide mediate pressure-evoked pain.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ffc37c14216e9d8b882d2f59a61e1034"><gtr:id>ffc37c14216e9d8b882d2f59a61e1034</gtr:id><gtr:otherNames>Drew LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8DC6EF4B-0565-44FB-A059-AD128C6F712C"><gtr:id>8DC6EF4B-0565-44FB-A059-AD128C6F712C</gtr:id><gtr:title>Sensory neuron voltage-gated sodium channels as analgesic drug targets.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9fb1de09bc3a0f6c74166f4997a9cab2"><gtr:id>9fb1de09bc3a0f6c74166f4997a9cab2</gtr:id><gtr:otherNames>Momin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2404E10F-5DF3-465E-A359-9AFA6AD80B42"><gtr:id>2404E10F-5DF3-465E-A359-9AFA6AD80B42</gtr:id><gtr:title>muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/000661e942319c254a47221a10d337e3"><gtr:id>000661e942319c254a47221a10d337e3</gtr:id><gtr:otherNames>Ekberg J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9257F69F-8240-466D-A184-A4782317E191"><gtr:id>9257F69F-8240-466D-A184-A4782317E191</gtr:id><gtr:title>FM1-43 is a permeant blocker of mechanosensitive ion channels in sensory neurons and inhibits behavioural responses to mechanical stimuli.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ffc37c14216e9d8b882d2f59a61e1034"><gtr:id>ffc37c14216e9d8b882d2f59a61e1034</gtr:id><gtr:otherNames>Drew LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8CE65BA1-FB21-4092-AE40-0CA3B1DA5C34"><gtr:id>8CE65BA1-FB21-4092-AE40-0CA3B1DA5C34</gtr:id><gtr:title>Increasingly irritable and close to tears: TRPA1 in inflammatory pain.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2a734c62c316a01144ed8b468a4099df"><gtr:id>2a734c62c316a01144ed8b468a4099df</gtr:id><gtr:otherNames>McMahon SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C54B7D15-17D6-4AF2-8FCF-A29C9C211F6B"><gtr:id>C54B7D15-17D6-4AF2-8FCF-A29C9C211F6B</gtr:id><gtr:title>A role for Piezo2 in EPAC1-dependent mechanical allodynia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de2ecc92d2fdbd6589be0f159e2a94d4"><gtr:id>de2ecc92d2fdbd6589be0f159e2a94d4</gtr:id><gtr:otherNames>Eijkelkamp N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3690B247-4E7D-4AD7-A2D2-B6565D18E3A6"><gtr:id>3690B247-4E7D-4AD7-A2D2-B6565D18E3A6</gtr:id><gtr:title>Worm sensation!</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ffc37c14216e9d8b882d2f59a61e1034"><gtr:id>ffc37c14216e9d8b882d2f59a61e1034</gtr:id><gtr:otherNames>Drew LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD59D6E3-F538-436B-94F5-E8502642DA2D"><gtr:id>DD59D6E3-F538-436B-94F5-E8502642DA2D</gtr:id><gtr:title>Na(v) 1.8-null mice show stimulus-dependent deficits in spinal neuronal activity.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0a9160af8554209ba5189f91edb3466d"><gtr:id>0a9160af8554209ba5189f91edb3466d</gtr:id><gtr:otherNames>Matthews EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16125D21-C5B2-45CE-84C2-36C2EF8ADE30"><gtr:id>16125D21-C5B2-45CE-84C2-36C2EF8ADE30</gtr:id><gtr:title>Genetic variation in SCN10A influences cardiac conduction.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a6331e598a783832f88337f69a52dc44"><gtr:id>a6331e598a783832f88337f69a52dc44</gtr:id><gtr:otherNames>Chambers JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86B99853-9B60-4984-A1D9-C2861639F5D4"><gtr:id>86B99853-9B60-4984-A1D9-C2861639F5D4</gtr:id><gtr:title>Mechanisms of cold pain.</gtr:title><gtr:parentPublicationTitle>Channels (Austin, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0de649583acd6e97642e6cfc9e413c0"><gtr:id>f0de649583acd6e97642e6cfc9e413c0</gtr:id><gtr:otherNames>Foulkes T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1933-6950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4B2C5869-74D7-49AC-800D-C7DFF5727F35"><gtr:id>4B2C5869-74D7-49AC-800D-C7DFF5727F35</gtr:id><gtr:title>The mechanosensitive cell line ND-C does not express functional thermoTRP channels.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eed844d05fc1e01d211d5eb3e0a2581c"><gtr:id>eed844d05fc1e01d211d5eb3e0a2581c</gtr:id><gtr:otherNames>Rugiero F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EBB14485-8EB3-4EEA-A03D-9B10CA99993D"><gtr:id>EBB14485-8EB3-4EEA-A03D-9B10CA99993D</gtr:id><gtr:title>Kinetic properties of mechanically activated currents in spinal sensory neurons.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eed844d05fc1e01d211d5eb3e0a2581c"><gtr:id>eed844d05fc1e01d211d5eb3e0a2581c</gtr:id><gtr:otherNames>Rugiero F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E6ADEB0F-0936-4C8F-B738-6E6354613245"><gtr:id>E6ADEB0F-0936-4C8F-B738-6E6354613245</gtr:id><gtr:title>The cell and molecular basis of mechanical, cold, and inflammatory pain.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d95ae01b58031d169b2d5e5fc544ccb"><gtr:id>1d95ae01b58031d169b2d5e5fc544ccb</gtr:id><gtr:otherNames>Abrahamsen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/96F2220D-431D-4D9E-8221-6682AC85F80F"><gtr:id>96F2220D-431D-4D9E-8221-6682AC85F80F</gtr:id><gtr:title>Regulation of ASIC activity by ASIC4--new insights into ASIC channel function revealed by a yeast two-hybrid assay.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/68c5df5295ee062fd5409a5171b60735"><gtr:id>68c5df5295ee062fd5409a5171b60735</gtr:id><gtr:otherNames>Donier E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/011A5480-C728-402A-B58A-FCAF5A1DB3A4"><gtr:id>011A5480-C728-402A-B58A-FCAF5A1DB3A4</gtr:id><gtr:title>A multi PDZ-domain protein Pdzd2 contributes to functional expression of sensory neuron-specific sodium channel Na(V)1.8.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/389c257b57485646aed29b91fe7e757b"><gtr:id>389c257b57485646aed29b91fe7e757b</gtr:id><gtr:otherNames>Shao D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FD70400E-8FC6-4182-AF94-FC132DA1B673"><gtr:id>FD70400E-8FC6-4182-AF94-FC132DA1B673</gtr:id><gtr:title>Tamoxifen-inducible NaV1.8-CreERT2 recombinase activity in nociceptive neurons of dorsal root ganglia.</gtr:title><gtr:parentPublicationTitle>Genesis (New York, N.Y. : 2000)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/11e74e5a3a7b3794a49aa81194f3c27f"><gtr:id>11e74e5a3a7b3794a49aa81194f3c27f</gtr:id><gtr:otherNames>Zhao J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1526-954X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/551EA34D-F3A1-4433-BC12-BBA1CB5CBE7C"><gtr:id>551EA34D-F3A1-4433-BC12-BBA1CB5CBE7C</gtr:id><gtr:title>The &amp;quot;Pain Matrix&amp;quot; in Pain-Free Individuals.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c316221b20c66c8cc8a05d1ae53c6f77"><gtr:id>c316221b20c66c8cc8a05d1ae53c6f77</gtr:id><gtr:otherNames>Salomons TV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C3947AF1-147E-4D8C-81E1-9F2A15783968"><gtr:id>C3947AF1-147E-4D8C-81E1-9F2A15783968</gtr:id><gtr:title>SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/78ae7b2dec84789e99df35ca42178798"><gtr:id>78ae7b2dec84789e99df35ca42178798</gtr:id><gtr:otherNames>Fertleman CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D69B0056-CDF1-4AB0-9920-5A0578051D9B"><gtr:id>D69B0056-CDF1-4AB0-9920-5A0578051D9B</gtr:id><gtr:title>Multiple postnatal craniofacial anomalies are characterized by conditional loss of polycystic kidney disease 2 (Pkd2).</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/53ebda0ef1d5f34531df76cc3306c305"><gtr:id>53ebda0ef1d5f34531df76cc3306c305</gtr:id><gtr:otherNames>Khonsari RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DBD40826-5E8A-4947-B4FD-057B51378B10"><gtr:id>DBD40826-5E8A-4947-B4FD-057B51378B10</gtr:id><gtr:title>Proteomic profiling of neuromas reveals alterations in protein composition and local protein synthesis in hyper-excitable nerves.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/774eb4855a45274d4e74f1af335ca562"><gtr:id>774eb4855a45274d4e74f1af335ca562</gtr:id><gtr:otherNames>Huang HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1A217A94-19BA-4236-9DAC-476E3AB65377"><gtr:id>1A217A94-19BA-4236-9DAC-476E3AB65377</gtr:id><gtr:title>Nociceptor-derived brain-derived neurotrophic factor regulates acute and inflammatory but not neuropathic pain.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/11e74e5a3a7b3794a49aa81194f3c27f"><gtr:id>11e74e5a3a7b3794a49aa81194f3c27f</gtr:id><gtr:otherNames>Zhao J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6E8BED06-5616-41C4-98F8-70FB4B3F80EF"><gtr:id>6E8BED06-5616-41C4-98F8-70FB4B3F80EF</gtr:id><gtr:title>Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9cc0219873a39ba68d81717aa20a8ab9"><gtr:id>9cc0219873a39ba68d81717aa20a8ab9</gtr:id><gtr:otherNames>Nassar MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5B4A03DF-597D-4F6D-B99F-8C429FB98544"><gtr:id>5B4A03DF-597D-4F6D-B99F-8C429FB98544</gtr:id><gtr:title>Nerve growth factor and pain.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/545704157c3b86379376f29ea8d635ca"><gtr:id>545704157c3b86379376f29ea8d635ca</gtr:id><gtr:otherNames>Wood JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/55016BB9-9C36-4786-A08D-A7C0D9E2217F"><gtr:id>55016BB9-9C36-4786-A08D-A7C0D9E2217F</gtr:id><gtr:title>Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba8639f773089688d1416cf618a8e473"><gtr:id>ba8639f773089688d1416cf618a8e473</gtr:id><gtr:otherNames>Wickramasinghe SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/71C87636-E5DA-4E90-9A10-1D62EF925B0D"><gtr:id>71C87636-E5DA-4E90-9A10-1D62EF925B0D</gtr:id><gtr:title>Deletion of annexin 2 light chain p11 in nociceptors causes deficits in somatosensory coding and pain behavior.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0de649583acd6e97642e6cfc9e413c0"><gtr:id>f0de649583acd6e97642e6cfc9e413c0</gtr:id><gtr:otherNames>Foulkes T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4D49A1C4-76BC-4C1E-BF8B-B6DBE30ADDA5"><gtr:id>4D49A1C4-76BC-4C1E-BF8B-B6DBE30ADDA5</gtr:id><gtr:title>An SCN9A channelopathy causes congenital inability to experience pain.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47d52ce5cf737af5897ceb23de3e4447"><gtr:id>47d52ce5cf737af5897ceb23de3e4447</gtr:id><gtr:otherNames>Cox JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4C890944-0EDC-42B5-B996-8F0B99DE4CBB"><gtr:id>4C890944-0EDC-42B5-B996-8F0B99DE4CBB</gtr:id><gtr:title>Chapter 5 Molecular mechanisms of nociception and pain.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/545704157c3b86379376f29ea8d635ca"><gtr:id>545704157c3b86379376f29ea8d635ca</gtr:id><gtr:otherNames>Wood JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/885C17BF-5A71-4AAD-83CC-1CB16ECB8B2C"><gtr:id>885C17BF-5A71-4AAD-83CC-1CB16ECB8B2C</gtr:id><gtr:title>The Yin and Yang of pain: variability in formalin test nociception and morphine analgesia produced by the Yin Yang 1 transcription factor gene.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfac99c86de594583d6149ba81759fd9"><gtr:id>cfac99c86de594583d6149ba81759fd9</gtr:id><gtr:otherNames>Sorge RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3293A8C0-C649-4DCF-9A07-B3431B5DE49A"><gtr:id>3293A8C0-C649-4DCF-9A07-B3431B5DE49A</gtr:id><gtr:title>Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bc468b4cd87bbe286277674b0a959e88"><gtr:id>bc468b4cd87bbe286277674b0a959e88</gtr:id><gtr:otherNames>Zimmermann K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/90D6A2AD-87DB-42F1-A720-187609100A95"><gtr:id>90D6A2AD-87DB-42F1-A720-187609100A95</gtr:id><gtr:title>Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7276d1e256346a632b0a5edf660a0b74"><gtr:id>7276d1e256346a632b0a5edf660a0b74</gtr:id><gtr:otherNames>Cregg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0FA2845E-897F-4AF4-9E03-A9D577F44458"><gtr:id>0FA2845E-897F-4AF4-9E03-A9D577F44458</gtr:id><gtr:title>Extensive co-localization and heteromultimer formation of the vanilloid receptor-like protein TRPV2 and the capsaicin receptor TRPV1 in the adult rat cerebral cortex.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17dacc26b3bf6ac2b89a655af2dda48a"><gtr:id>17dacc26b3bf6ac2b89a655af2dda48a</gtr:id><gtr:otherNames>Liapi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D92220B1-8CAE-4DCF-B4F4-36E5094DDBA7"><gtr:id>D92220B1-8CAE-4DCF-B4F4-36E5094DDBA7</gtr:id><gtr:title>Fat location defines sensation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4c309499c23cd3668d70c012479e76b4"><gtr:id>4c309499c23cd3668d70c012479e76b4</gtr:id><gtr:otherNames>Oh U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FDEA5600-2F22-4C50-B94E-F343A2AB6E98"><gtr:id>FDEA5600-2F22-4C50-B94E-F343A2AB6E98</gtr:id><gtr:title>Parallel &amp;quot;pain&amp;quot; pathways arise from subpopulations of primary afferent nociceptor.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/610fe43da1bded81365b23e709706035"><gtr:id>610fe43da1bded81365b23e709706035</gtr:id><gtr:otherNames>Braz JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C895163A-0E72-47C2-BDE0-594DD322AF1A"><gtr:id>C895163A-0E72-47C2-BDE0-594DD322AF1A</gtr:id><gtr:title>Sensory axon-derived neuregulin-1 is required for axoglial signaling and normal sensory function but not for long-term axon maintenance.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/efbbcf36cead44d744308d49d79f1f9f"><gtr:id>efbbcf36cead44d744308d49d79f1f9f</gtr:id><gtr:otherNames>Fricker FR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C5FA44C0-F0A7-4353-AE97-FE23CF39BC9D"><gtr:id>C5FA44C0-F0A7-4353-AE97-FE23CF39BC9D</gtr:id><gtr:title>Annexin II light chain p11 promotes functional expression of acid-sensing ion channel ASIC1a.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/68c5df5295ee062fd5409a5171b60735"><gtr:id>68c5df5295ee062fd5409a5171b60735</gtr:id><gtr:otherNames>Donier E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C608FF6-5262-4B9E-915D-E8FA0137FF92"><gtr:id>7C608FF6-5262-4B9E-915D-E8FA0137FF92</gtr:id><gtr:title>A sensory subpopulation depends on vesicular glutamate transporter 2 for mechanical pain, and together with substance P, inflammatory pain.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5a3a6602e21704a5beeebc61fa2c9f3a"><gtr:id>5a3a6602e21704a5beeebc61fa2c9f3a</gtr:id><gtr:otherNames>Lagerstr?m MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1CBEBB65-1767-403D-B1E9-2CE0DBBFEBD8"><gtr:id>1CBEBB65-1767-403D-B1E9-2CE0DBBFEBD8</gtr:id><gtr:title>Nociceptor-expressed ephrin-B2 regulates inflammatory and neuropathic pain.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/11e74e5a3a7b3794a49aa81194f3c27f"><gtr:id>11e74e5a3a7b3794a49aa81194f3c27f</gtr:id><gtr:otherNames>Zhao J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3179D32E-C4C6-4A0E-AB73-E08D0C9C8A37"><gtr:id>3179D32E-C4C6-4A0E-AB73-E08D0C9C8A37</gtr:id><gtr:title>Nociceptor-specific gene deletion using heterozygous NaV1.8-Cre recombinase mice.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a52c12928e4a3a32746521c2465e169"><gtr:id>4a52c12928e4a3a32746521c2465e169</gtr:id><gtr:otherNames>Stirling LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CE3A1DA8-B53E-45D1-95F7-D73C1E861C09"><gtr:id>CE3A1DA8-B53E-45D1-95F7-D73C1E861C09</gtr:id><gtr:title>Acid-sensing ion channels ASIC2 and ASIC3 do not contribute to mechanically activated currents in mammalian sensory neurones.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ffc37c14216e9d8b882d2f59a61e1034"><gtr:id>ffc37c14216e9d8b882d2f59a61e1034</gtr:id><gtr:otherNames>Drew LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/241513CE-3D7D-46A1-9D44-B797216A4AA1"><gtr:id>241513CE-3D7D-46A1-9D44-B797216A4AA1</gtr:id><gtr:title>Ion channels in analgesia research.</gtr:title><gtr:parentPublicationTitle>Handbook of experimental pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/545704157c3b86379376f29ea8d635ca"><gtr:id>545704157c3b86379376f29ea8d635ca</gtr:id><gtr:otherNames>Wood JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0171-2004</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16F8B686-648D-46B0-BC45-86C3782981E6"><gtr:id>16F8B686-648D-46B0-BC45-86C3782981E6</gtr:id><gtr:title>Pain genes.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0de649583acd6e97642e6cfc9e413c0"><gtr:id>f0de649583acd6e97642e6cfc9e413c0</gtr:id><gtr:otherNames>Foulkes T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/284D645D-EE44-48A8-8D58-4530216369BF"><gtr:id>284D645D-EE44-48A8-8D58-4530216369BF</gtr:id><gtr:title>Nerve injury induces robust allodynia and ectopic discharges in Nav1.3 null mutant mice.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9cc0219873a39ba68d81717aa20a8ab9"><gtr:id>9cc0219873a39ba68d81717aa20a8ab9</gtr:id><gtr:otherNames>Nassar MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/716DBB9A-91A0-4627-9A67-C70B1FA4B428"><gtr:id>716DBB9A-91A0-4627-9A67-C70B1FA4B428</gtr:id><gtr:title>A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25ade2c021da81e3dd342516d183a560"><gtr:id>25ade2c021da81e3dd342516d183a560</gtr:id><gtr:otherNames>Kremeyer B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49879136-6B85-4829-BD25-B3D3BE24D175"><gtr:id>49879136-6B85-4829-BD25-B3D3BE24D175</gtr:id><gtr:title>Voltage-gated sodium channel blockers; target validation and therapeutic potential.</gtr:title><gtr:parentPublicationTitle>Current topics in medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/545704157c3b86379376f29ea8d635ca"><gtr:id>545704157c3b86379376f29ea8d635ca</gtr:id><gtr:otherNames>Wood JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1568-0266</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BC52C3D4-7281-4A8B-ACDF-36E392F07211"><gtr:id>BC52C3D4-7281-4A8B-ACDF-36E392F07211</gtr:id><gtr:title>Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9cc0219873a39ba68d81717aa20a8ab9"><gtr:id>9cc0219873a39ba68d81717aa20a8ab9</gtr:id><gtr:otherNames>Nassar MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2283D7C6-68BE-45E1-9610-1119BC4BD175"><gtr:id>2283D7C6-68BE-45E1-9610-1119BC4BD175</gtr:id><gtr:title>Pyramidal cells of rodent presubiculum express a tetrodotoxin-insensitive Na+ current.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a3952e75c41fbd491907ba234ab90d44"><gtr:id>a3952e75c41fbd491907ba234ab90d44</gtr:id><gtr:otherNames>Fricker D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3F87F32A-AE21-46A8-9BD1-61B7E247E62E"><gtr:id>3F87F32A-AE21-46A8-9BD1-61B7E247E62E</gtr:id><gtr:title>Pain channelopathies.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7276d1e256346a632b0a5edf660a0b74"><gtr:id>7276d1e256346a632b0a5edf660a0b74</gtr:id><gtr:otherNames>Cregg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E3EDFD74-E99E-4979-ACFC-8D99F21B48D6"><gtr:id>E3EDFD74-E99E-4979-ACFC-8D99F21B48D6</gtr:id><gtr:title>Modulation of sensory neuron mechanotransduction by PKC- and nerve growth factor-dependent pathways.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/933b3a30380bf7b38e49cf25a1edda79"><gtr:id>933b3a30380bf7b38e49cf25a1edda79</gtr:id><gtr:otherNames>Di Castro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D232E4AF-EF2E-4AB7-AAB0-B6625D3BA65E"><gtr:id>D232E4AF-EF2E-4AB7-AAB0-B6625D3BA65E</gtr:id><gtr:title>GTP up-regulated persistent Na+ current and enhanced nociceptor excitability require NaV1.9.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/19e7eb7120a893a8e98c9e5df67cb829"><gtr:id>19e7eb7120a893a8e98c9e5df67cb829</gtr:id><gtr:otherNames>Ostman JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E77AD2A-5B6A-4E92-A48F-73AA5CDD8A22"><gtr:id>0E77AD2A-5B6A-4E92-A48F-73AA5CDD8A22</gtr:id><gtr:title>RET signaling is required for survival and normal function of nonpeptidergic nociceptors.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad3a147c20843a4ad1bca976850521bd"><gtr:id>ad3a147c20843a4ad1bca976850521bd</gtr:id><gtr:otherNames>Golden JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9717869</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>